Pfizer
-
healthModerna CEO Warns Europe Is Vulnerable Without mRNA Manufacturing Capacity
Stéphane Bancel cautions that continental Europe lacks industrial mRNA infrastructure, leaving it exposed to future pandemics or bioterrorism, as Moderna shifts strategy toward cancer vaccines.
-
healthRSV Vaccine Uptake Low Among Pregnant Women in Singapore Despite Approval
Nearly two years after approval, RSV vaccine uptake among pregnant women in Singapore remains low, with no significant drop in infant hospitalizations.
-
financeTrump Orders Up to 100% Tariffs on Patented Drugs
President Trump signs executive order imposing tiered tariffs on imported patented drugs, offering exemptions for firms relocating production to the U.S. and negotiating pricing deals.
-
worldTrump Imposes 100% Tariff on Branded Drugs
President Trump announces 100% tariffs on imported patented drugs unless manufacturers comply with new pricing agreements or produce in the U.S.
-
healthPfizer and Valneva Report 70% Efficacy for Lyme Disease Vaccine Candidate
Major breakthrough as Pfizer and Valneva announce promising Phase 3 results for PF-07307405, marking a potential first-line defense against Lyme disease with strong safety profiles.